Researchers demonstrated that calreticulin facilitated breast cancer progression by promoting the breast cancer stem cell phenotype through Wnt/β-catenin signaling in a hypoxia-inducible factor 1 (HIF-1)–dependent manner.
[Proceedings of the National Academy of Sciences of the United States of America]
7992332
{7992332:AAAAAAAA}
apa
50
1
168596
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
